JENNIFER VANCE: Open Payments
NPI 1891361234 · HUNTINGDON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,207 in 66 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $422 · 2025 $1,207
Food & beverage: $1,207
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $186 |
| Daiichi Sankyo Inc. | 9 | $150 |
| Incyte Corporation | 10 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 6 | $101 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| Acrotech Biopharma Inc. | 3 | $77 |
| Geron Corporation | 3 | $72 |
| Eisai Inc. | 3 | $65 |
| PharmaEssentia USA Corporation | 3 | $63 |
Products named: KEYTRUDA, Enhertu, JAKAFI, OPDIVO, ORGOVYX, BELEODAQ, RYTELO, Lenvima.
Industry payments across PA — which companies pay providers there.
